Astec Lifesciences Ltd

Astec Lifescienc | 533138

Market Closed

₹637.20

+₹0.00 (+0.85%)

As on 19/11/25, 2:32 AM

Market Cap1,407.87 CR

Current Price₹637.2

High / Low₹1,254.26 / 607.05

PE Ratio-9.82

Book Value₹119.7

Dividend Yield0.00%

ROCE-12.60%

ROE-44.73%

Face Value₹2.00

Current Vol.16,295

Average Vol.12,76,53,456

ISININE563J01010

PB Ratio5.64

Debt to Equity1.74

Net Profit Margin-35.33

Operating Margin-15.89

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Astec LifeSciences Limited was initially incorporated on January 25, 1994 as a private limited Company as 'Urshila Traders Private Limited'
The Company was originally promoted by Reena Bagai and Avita Fernandes
Their shareholding was purchased by Ashok Hiremath and Pratap Garud on February 11, 1994
On August 19, 1994, the name of the Company was changed from Urshila Traders Private Limited to Astec Chemicals Private Limited
In March 2006, the name was changed from Astec Chemicals Private Limited to Astec LifeSciences Private Limited
In April 2006, the company was converted into public limited Company and the name was changed to Astec LifeSciences Limited
Astec LifeSciences is a producer of agrochemicals and pharmaceutical intermediates
The Company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates
They are having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz
one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2)

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI33.04

SMA 20659.33

SMA 50751.09

SMA 100815.35

SMA 200782.02

SMA 10635.87

MACD_12_26_Days-36.18

EMA10Day638.54

EMA20Day663.93

EMA50Day725.11

MACD_12_26_9_Days2.56

EMA100Day768.39

EMA200Day821.00

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth-16.78%

ROE-44.60%

EBITDA Margin-15.89%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	381.30	458.18	628.17	676.57	554.87
Interest	36.70	25.23	20.71	9.06	4.75
Expenses	447.51	464.09	551.91	522.49	443.32
Financing Profit	-60.58	-0.27	89.31	164.54	119.48
Financing Margin %	-16%	-0%	14%	24%	22%
Other Income	5.63	5.64	13.06	10.47	7.92
Depreciation	43.71	36.25	33.65	34.36	25.66
Profit before tax	-140.99	-61.75	34.95	121.13	89.07
Tax %	4%	24%	27%	26%	27%
Net Profit	-134.71	-46.89	25.59	89.88	65.07
EPS in Rs	-68.71	-23.93	13.04	45.87	33.23

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

28 Jul 2025

AGM

23 Apr 2025

04 Jul 2025

Rights Issue (1:7)

1:7 Rights Issue of Equity Shares

30 Jun 2025

29 Jul 2024

AGM

02 May 2024

27 Jul 2023

AGM

02 May 2023

22 Jul 2023

Final Dividend (₹1.5)

The Board of Directors has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty ) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) each for the Financial Year ended 31st March, 2023, subject to approval of the Shareholders at the ensuing 29th (Twenty Ninth) Annual General Meeting of the Company.

02 May 2023

25 Jul 2022

AGM

02 May 2022

21 Jul 2022

Final Dividend (₹1.5)

The Board of Directors at its Meeting held on 2nd May, 2022 has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e. Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) for the Financial Year ended 31st March, 2022, subject to approval of the Shareholders at the ensuing 28th (Twenty Eighth) Annual General Meeting of the Company.

02 May 2022

28 Jul 2021

AGM

30 Apr 2021

24 Jul 2021

Final Dividend (₹1.5)

The Board of Directors at its Meeting held on 30th April, 2021 has recommended Final Dividend of 15% (Fifteen per cent) on the Equity Share Capital of the Company, i.e., Rs.1.50 (Rupee One and Paise Fifty) per Equity Share of Face Value of Rs.10/- (Rupees Ten Only) for the Financial Year ended 31st March, 2021, subject to approval of the Shareholders at the ensuing 27th (Twenty Seventh) Annual General Meeting of the Company.

30 Apr 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
650	1,449	0	4	0	2	-35.33%
760	64,067	27	2	12	1	1.74%
3,458	52,469	35	5	28	0	20.81%
456	22,771	42	7	37	0	16.09%
772	6,963	15	3	9	0	6.88%
1,237	5,637	19	4	16	0	14.59%
10,184	4,232	29	4	25	0	12.01%
193	3,884	0	9	0	1	-9.78%
253	3,277	269	5	120	0	3.15%
178	2,046	20	2	16	0	9.92%

Showing 10 of 23 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Astec Lifesciences Ltd?

The current share price of Astec Lifesciences Ltd (Astec Lifescienc) is ₹637.20. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Astec Lifesciences Ltd?

The Price-to-Earnings (P/E) ratio of Astec Lifesciences Ltd is 637.20. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Astec Lifesciences Ltd?

Astec Lifesciences Ltd has a 52-week high of ₹1254.26 and a 52-week low of ₹607.05. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Astec Lifesciences Ltd?

Astec Lifesciences Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Astec Lifesciences Ltd?

The Earnings Per Share (EPS) of Astec Lifesciences Ltd is ₹-51.13. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Astec Lifesciences Ltd?

Astec Lifesciences Ltd has a Return on Equity (ROE) of -44.73%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.